Demographic and clinical characteristics | Patients assessed N = 340 | Patients who died within 90 days n = 33 | Patients who survived 90-days without LT n = 297 | p-value |
---|---|---|---|---|
Age | 56 ± 11 | 57 ± 9 | 56 ± 9 | 0.5 |
Gender (male) (%) | 63 | 21 | 40 | 0.04 |
Race (%) | ||||
White | 90 | 85 | 91 | 0.6 |
Black | 5 | 9 | 4 | |
Hispanic | 3 | 6 | 3 | |
Asian | 1 | None | 1 | |
Other | 1 | None | 1 | |
Body mass index | 30 ± 7 | 30 ± 8 | 30 ± 6 | 0.7 |
Etiology of liver disease (%) | ||||
Alcohol | 19 | 12 | 20 | 0.4 |
Alcohol and viral | 16 | 24 | 16 | |
Viral | 32 | 39 | 31 | |
Autoimmune | 8 | None | 8 | |
Fatty liver | 21 | 21 | 21 | |
Cryptogenic | 2 | 3 | 2 | |
MELD-Na | 17.2 ± 6.6 | 25.1 ± 7.3 | 16.2 ± 5.8 | < 0.001 |
Hepatocellular carcinoma (%) | 24 | 30 | 23 | 0.4 |
CCI (mean) | 1 ± 1.2 | 1.4 ± 1.2 | 1 ± 1.2 | 0.09 |
(median (IQR)) | 1 (0,1) | 1 (0, 2) | 1 (0,1) | |
CCI category (%) | ||||
CCI = 0 | 44 | 30 | 46 | 0.07 |
CCI = 1–2 | 44 | 52 | 43 | |
CCI > 2 | 12 | 18 | 110. | |
CIRCOM (mean) | 0.8 ± 1.2 | 1.6 ± 1.4 | 0. ± 1.1 | 0.001 |
(median (IQR)) | 0 (0,1) | 1 (0, 3) | 0 (0,1) |